Skip to main content
Download PDF

Correction to: Angiosarcoma patients treated with immune checkpoint inhibitors: a case series of seven patients from a single institution

Journal for ImmunoTherapy of Cancer volume 7, Article number: 285 (2019) Cite this article

The Original Article was published on 08 August 2019

Correction to: J ImmunoTher Cancer

https://doi.org/10.1186/s40425-019-0689-7

Following publication of the original article [1], the authors have reported that the following sentence “While of the same IgG1 class as ipilimumab, preclinical data suggests this molecule may have enhanced activity against T regulatory cells.”

should be replaced with

“Ipilimumab and AGEN1884 are IgG1 class antibodies. AGEN1884 data show CTLA-4 inhibition and activity against T regulatory cells (reference 8).”

Reference

  1. Florou, et al. Angiosarcoma patients treated with immune checkpoint inhibitors: a case series of seven patients from a single institution. J ImmunoTher Cancer. 2019;7:213. https://doi.org/10.1186/s40425-019-0689-7.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Division of Oncology, Sylvester Comprehensive Cancer Center at University of Miami Miller School of Medicine, 1475 NW 12th Avenue, Miami, FL, 33136, USA

    Vaia Florou, Andrew E. Rosenberg, Eric Wieder, Krishna V. Komanduri, Despina Kolonias, Jonathan C. Trent & Breelyn A. Wilky

  2. Agenus Inc., 3 Forbes Road, Lexington, MA, 02421, USA

    Mohamed Uduman, John C. Castle & Jennifer S. Buell

Authors
  1. Vaia Florou
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andrew E. Rosenberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Eric Wieder
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Krishna V. Komanduri
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Despina Kolonias
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Mohamed Uduman
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. John C. Castle
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Jennifer S. Buell
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Jonathan C. Trent
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Breelyn A. Wilky
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Vaia Florou.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Florou, V., Rosenberg, A.E., Wieder, E. et al. Correction to: Angiosarcoma patients treated with immune checkpoint inhibitors: a case series of seven patients from a single institution. j. immunotherapy cancer 7, 285 (2019). https://doi.org/10.1186/s40425-019-0792-9

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s40425-019-0792-9